United States · 
What does Illumina invest in?
Illumina invests most often at Series B and Seed (58% of the rounds on record), in sectors such as Genomics, Sequencing and Microarrays.
Illumina highlights
- 01
15 rounds on record
- 02
Mostly Series B and Seed: 58% of its rounds
- 03
Sole investor in 3 rounds, median $120K
- 04
1 exits from the portfolio
What they do
Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.From their own website
- Type
- Company
- Cheque size
- Not stated
- Stages
- GrowthSeedSeries A
- Sectors
- GenomicsSequencingMicroarrays
- Based in
- United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first15 appearances
- 2019
2 rounds
- May
- May
- 2018
4 rounds
- Dec
- Aug
- May
- Feb
- 2017
1 round
- Nov
- 2015
1 round
- Jun
- 2014
4 rounds
- Oct
- Oct
- Oct
- Mar
- 2012
1 round
- Feb
- 2010
1 round
- Apr
- 2006
1 round
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
GenoLogicsBought by IlluminaUndisclosedAug 2015
An exit counts when it came after the firm's first round in the company. From historical deal records.
Companies it bought
Acquisitions by the firm itself
GenoLogicsUndisclosedAug 2015
NextBioUndisclosedOct 2013
Advanced Liquid Logic$96MJul 2013
Verinata HealthUndisclosedJan 2013
HelixisUndisclosedApr 2010